Inhibitor Therapeutics, Inc. Earnings Per Share (Basic)
Inhibitor Therapeutics, Inc. (INTI) reported Earnings Per Share (Basic) of $0.00 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Inhibitor Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.00.
- Inhibitor Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.00.
- Inhibitor Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.00.
- Inhibitor Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was $0.00.
- Inhibitor Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$0.02.
- Inhibitor Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$0.02.
- Inhibitor Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$0.02, a 166.67% decline from fiscal 2022.
- Inhibitor Therapeutics, Inc. earnings per share, basic for fiscal 2022 was $0.03.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | -$0.01 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | -$0.02 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | -$0.01 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | -$0.01 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | -$0.02 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | -$0.01 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 | -$0.01 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.02 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | -$0.01 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.01 10-Q · filed 2024-11-12 | $0.05 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | -$0.01 10-Q · filed 2024-08-06 | $0.05 derived: net income ÷ weighted average shares · filed 2024-08-06 | $0.04 derived: net income ÷ weighted average shares · filed 2024-08-06 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | $0.05 derived: net income ÷ weighted average shares · filed 2024-05-13 | $0.04 derived: net income ÷ weighted average shares · filed 2024-05-13 | $0.04 derived: net income ÷ weighted average shares · filed 2024-05-13 |
| 2022-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2024-03-29 | $0.03 derived: net income ÷ weighted average shares · filed 2024-03-29 | $0.03 derived: net income ÷ weighted average shares · filed 2024-03-29 | $0.03 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||
| 2013-12-31 | -$0.10 10-K · filed 2014-04-15 | |||
| 2012-12-31 | $0.01 10-K · filed 2014-04-15 |